Aderis Pharmaceuticals
Home | Search | Contact Us | Site Map
About UsNews and EventsProducts in DevelopmentSciencePatient Center

Overview
Press Releases
Presentations & Articles
Events
FAQs

Request Information


Current : 2002 : 2001 : 2000 : 1999 


Apr 24, 2000
Discovery Therapeutics Initiates DTI–0009 Phase II Clinical Trial For Atrial Fibrillation
  New generation drug to be tested for ability to restore normal heart rhythm


Jan 5, 2000
Discovery Therapeutics, Inc. and Schwarz Pharma AG to broaden collaboration
  Discovery Therapeutics, Inc. grants worldwide rights for Parkinson-Patch

back to top





"At Aderis, we are excited about the progress of our product candidates and their potential ability to improve quality of life for millions of people. We are committed to helping patients and investors understand our progress as we achieve corporate and clinical milestones."

-Kenneth L. Rice, Jr.,
Chief Commercial Officer,
Aderis Pharmaceuticals




© 2001 - 2004 ADERIS Pharmaceuticals, Inc.    Trademarks and Terms of Use

Created by PixelMEDIA, Inc. © 2003  
News and Eventspress releases